Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
8m
Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
The FDA approves BMY's differentiated schizophrenia treatment for adults and broadens its diverse portfolio. Shares gain.
Medscape
27m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
'Harry Potter' star dies
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Ending password-sharing
Boxes to distribute Narcan
Producing doc on Diddy
Urgent safety alert for 737s
Targeted Black residents?
Fake Biden robocalls fine
Stadiums to serve as shelters
More executives leave
On Secret Service failures
Chinese submarine sank
NC board removes 747K
NIH finds misconduct
Arrives in Luxembourg
WI duplicate ballot flap
Capital goods orders up
Rose announces retirement
Military recruiting rebounds
RU hits Ukraine's power grid
Related topics
Bristol-Myers Squibb
Food and Drug Administration
Schizophrenia
Cobenfy
Feedback